Skip to main content
SpringerLink
Log in

Neuropathie und diabetisches Fußsyndrom

Neuropathy and diabetic foot ulcers

  • Schwerpunkt
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Das diabetische Fußsyndrom ist weltweit eine der bedeutendsten Komplikationen des Diabetes mellitus. Zudem ist es der häufigste Grund für eine Krankenhausbehandlung. Die Ätiologie des diabetischen Fußsyndroms ist multifaktoriell und komplex. Pathophysiologisch steht die Polyneuropathie im Vordergrund. Durch geeignete Behandlungsstrategien sowie interdisziplinäre und sektorenübergreifende Strukturen ist es möglich, die Amputationsraten zu senken.

Abstract

Diabetic foot ulceration is a serious complication of diabetes mellitus worldwide and the most common cause of hospitalization in diabetic patients. The etiology of diabetic foot ulcerations is complex due to their multifactorial nature. Polyneuropathy plays an important role in the pathophysiology of diabetic foot ulceration. Proper adherence to standard treatment strategies and interdisciplinary cooperation can reduce the high rates of major amputations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Andersen H (2012) Motor dysfunction in diabetes. Diabetes Metab Res Rev 28(Suppl 1):89–92

    Article  PubMed  Google Scholar 

  2. Barker AR, Rosson GD, Dellon AL (2006) Wound healing in denervated tissue. Ann Plast Surg 57:339–342

    Article  CAS  PubMed  Google Scholar 

  3. Bentley J, Foster A (2007) Multidisciplinary management of the diabetic foot ulcer. Br J Community Nurs 12:S6, S8, S10 passim

    PubMed  Google Scholar 

  4. Boulton AJ (2008) The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev 24(Suppl 1):S3–S6

    Article  PubMed  Google Scholar 

  5. Boulton AJ (2014) Diabetic neuropathy and foot complications. Handb Clin Neurol 126:97–107

    Article  PubMed  Google Scholar 

  6. Boulton AJ (2013) The pathway to foot ulceration in diabetes. Med Clin North Am 97:775–790

    Article  PubMed  Google Scholar 

  7. Boulton AJ (2010) What you can’t feel can hurt you. J Vasc Surg 52:28S–30S

  8. Boulton AJ, Kirsner RS, Vileikyte L (2004) Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med 351:48–55

  9. Brandner JM, Zacheja S, Houdek P et al (2008) Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model. Diabetes Care 31:114–120

    Article  CAS  PubMed  Google Scholar 

  10. Broussard KC, Powers JG (2013) Wound dressings: selecting the most appropriate type. Am J Clin Dermatol 14:449–459

    Article  PubMed  Google Scholar 

  11. Bruhn-Olszewska B, Korzon-Burakowska A, Gabig-Ciminska M et al (2012) Molecular factors involved in the development of diabetic foot syndrome. Acta Biochim Pol 59:507–513

    CAS  PubMed  Google Scholar 

  12. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter – Langfassung. Version 1.2, 2011. http://www.diabetes.versorgungsleitlinien.de; http://www.versorgungsleitlinien.de; http://www.awmf-leitlinien.de. Zugegriffen: 2. Februar 2015

  13. Cavanagh PR, Bus SA (2011) Off-loading the diabetic foot for ulcer prevention and healing. Plast Reconstr Surg 127(Suppl 1):248S–256S

    Article  CAS  PubMed  Google Scholar 

  14. Cavanagh PR, Bus SA (2010) Off-loading the diabetic foot for ulcer prevention and healing. J Am Podiatr Med Assoc 100:360–368

  15. Da Silva L, Carvalho E, Cruz MT (2010) Role of neuropeptides in skin inflammation and its involvement in diabetic wound healing. Expert Opin Biol Ther 10:1427–1439

    Article  Google Scholar 

  16. Generini S, Tuveri MA, Matucci Cerinic M et al (2004) Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. Exp Clin Endocrinol Diabetes 112:542–544

    Article  CAS  PubMed  Google Scholar 

  17. Gilbey SG (2004) Neuropathy and foot problems in diabetes. Clin Med 4:318–323

    Article  CAS  PubMed  Google Scholar 

  18. Graiani G, Emanueli C, Desortes E et al (2004) Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia 47:1047–1054

    Article  CAS  PubMed  Google Scholar 

  19. Hochlenert D, Engels G (2007) Integrated management in patients with diabetic foot syndrome. MMW Fortschr Med 149:41–43

    CAS  PubMed  Google Scholar 

  20. Jeffcoate WJ (2012) Wound healing – a practical algorithm. Diabetes Metab Res Rev 28(Suppl 1):85–88

    Article  PubMed  Google Scholar 

  21. Kamenov ZA, Traykov LD (2012) Diabetic autonomic neuropathy. Adv Exp Med Biol 771:176–193

    PubMed  Google Scholar 

  22. Kamenov ZA, Traykov LD (2012) Diabetic somatic neuropathy. Adv Exp Med Biol 771:155–175

    PubMed  Google Scholar 

  23. Krishnan ST, Quattrini C, Jeziorska M et al (2007) Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects. Diabetes Care 30:3058–3062

    Article  PubMed  Google Scholar 

  24. Lobmann R (2011) Diabetic foot syndrome. Internist 52:539–548

    Article  CAS  PubMed  Google Scholar 

  25. Lobmann R (2013) Diabetic foot: how to avoid therapeutic mistakes. MMW Fortschr Med 155:63–66

    Article  CAS  PubMed  Google Scholar 

  26. Lobmann R, Achwerdov O, Brunk-Loch S et al (2014) The diabetic foot in Germany 2005–2012: Analysis of quality in specialized diabetic foot care centers. Wound Med 4:27–29

    Article  Google Scholar 

  27. Lobmann R, Ambrosch A, Schultz G et al (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45:1011–1016

    Article  CAS  PubMed  Google Scholar 

  28. Lobmann R, Schultz G, Lehnert H (2005) Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 28:461–471

    Article  CAS  PubMed  Google Scholar 

  29. Molines L, Darmon P, Raccah D (2010) Charcot’s foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab 36:251–255

    Article  CAS  PubMed  Google Scholar 

  30. Monteiro-Soares M, Boyko EJ, Ribeiro J et al (2011) Risk stratification systems for diabetic foot ulcers: a systematic review. Diabetologia 54:1190–1199

    Article  CAS  PubMed  Google Scholar 

  31. Morbach S, Muller E, Reike H et al (2014) Diabetic foot syndrome. Exp Clin Endocrinol Diabetes 122:416–424

    Article  CAS  PubMed  Google Scholar 

  32. Motzkau M, Tautenhahn J, Lehnert H et al (2011) Expression of matrix-metalloproteases in the fluid of chronic diabetic foot wounds treated with a protease absorbent dressing. Exp Clin Endocrinol Diabetes 119:286–290

    Article  CAS  PubMed  Google Scholar 

  33. Mulder G, Tenenhaus M, D’Souza GF (2014) Reduction of diabetic foot ulcer healing times through use of advanced treatment modalities. Int J Low Extrem Wounds 13:335–346

    Article  PubMed  Google Scholar 

  34. Peltier A, Goutman SA, Callaghan BC (2014) Painful diabetic neuropathy. BMJ 348:g1799

    Article  PubMed  Google Scholar 

  35. Pereira Da Silva L, Miguel Neves B, Moura L et al (2014) Neurotensin decreases the proinflammatory status of human skin fibroblasts and increases epidermal growth factor expression. Int J Inflam 2014:248240

    Google Scholar 

  36. Rhim B, Harkless L (2012) Prevention: can we stop problems before they arise? Semin Vasc Surg 25:122–128

    Article  PubMed  Google Scholar 

  37. Risse A (2007) The diabetic foot syndrome – an interdisciplinary challenge. Hamostaseologie 27:117–122

    CAS  PubMed  Google Scholar 

  38. Robinson C, Major MJ, Kuffel C et al (2015) Orthotic management of the neuropathic foot: an interdisciplinary care perspective. Prosthet Orthot Int 39:73–81

    Article  PubMed  Google Scholar 

  39. Rumenapf G, Dittler S, Morbach S et al (2008) The vascular surgeon’s role in interdisciplinary treatment of diabetic foot syndrome. Chirurg 79:535–545

    Article  CAS  PubMed  Google Scholar 

  40. Russell JW, Zilliox LA (2014) Diabetic neuropathies. Continuum 20:1226–1240

    PubMed  Google Scholar 

  41. Said G (2013) Diabetic neuropathy. Handb Clin Neurol 115:579–589

    Article  PubMed  Google Scholar 

  42. Sandireddy R, Yerra VG, Areti A et al (2014) Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int J Endocrinol 2014:674987

    Article  PubMed Central  PubMed  Google Scholar 

  43. Shalaby SY, Blume P, Sumpio BE (2014) New modalities in the chronic ischemic diabetic foot management. Clin Podiatr Med Surg 31:27–42

    Article  PubMed  Google Scholar 

  44. Singh VP, Bali A, Singh N et al (2014) Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 18:1–14

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Soliman M, Rajbhandari SM (2013) Assessing outcome of diabetic foot ulcers and multidisciplinary foot clinic. Curr Diabetes Rev 9:397–401

    Article  CAS  PubMed  Google Scholar 

  46. Tavee J, Zhou L (2009) Small fiber neuropathy: a burning problem. Cleve Clin J Med 76:297–305

    Article  PubMed  Google Scholar 

  47. Tiaka EK, Papanas N, Manolakis AC et al (2011) The role of nerve growth factor in the prophylaxis and treatment of diabetic foot ulcers. Int J Burns Trauma 1:68–76

    PubMed Central  CAS  PubMed  Google Scholar 

  48. Van Battum P, Schaper N, Prompers L et al (2011) Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 28:199–205

    Article  Google Scholar 

  49. Vinik AI, Maser RE, Mitchell BD et al (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579

    Article  PubMed  Google Scholar 

  50. Wukich DK, Armstrong DG, Attinger CE et al (2013) Inpatient management of diabetic foot disorders: a clinical guide. Diabetes Care 36:2862–2871

    Article  PubMed Central  PubMed  Google Scholar 

  51. Zenker J, Ziegler D, Chrast R (2013) Novel pathogenic pathways in diabetic neuropathy. Trends Neurosci 36:439–449

    Article  CAS  PubMed  Google Scholar 

  52. Ziegler D, Keller J, Maier C et al (2014) Diabetic neuropathy. Exp Clin Endocrinol Diabetes 122:406–415

    Article  CAS  PubMed  Google Scholar 

  53. Zimmermann A, Reeps C, Hartl F et al (2009) The diabetic foot. Chirurg 80:430–436

    Article  CAS  PubMed  Google Scholar 

  54. Boucek P (2006) Advanced diabetic neuropathy: a point of no return? Rev Diabet Stud 3:143–150

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. R. Lobmann: Vortragstätigkeit für Lilly, Novo Nordisk, Novartis, MSD, Boehringer Ingelheim, AstraZeneca, Sanofi Aventis, URGO, Pfizer und Wörwag; Beratertätigkeit für Lilly, URGO und Wörwag.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Alle Patienten, die über Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben. Im Falle von nicht mündigen Patienten liegt die Einwilligung eines Erziehungsberechtigen oder des gesetzlich bestellten Betreuers vor.

Author information

Authors and Affiliations

  1. Klinik für Endokrinologie, Diabetologie und Geriatrie, Klinikum Stuttgart – Bürgerhospital, Tunzhofer Str. 14–16, 70191, Stuttgart, Deutschland

    R. Lobmann

Authors
  1. R. Lobmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Lobmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lobmann, R. Neuropathie und diabetisches Fußsyndrom. Internist 56, 503–512 (2015). https://doi.org/10.1007/s00108-014-3630-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-014-3630-7

Schlüsselwörter

Keywords

Search

Navigation